The latest closing stock price for CRISPR Therapeutics AG as of November 20, 2024 is 47.26.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,354 today, roughly 2 times their original investment - a 16.33% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 91.10, which is 92.8% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 43.42, which is 8.1% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 58.71.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,354 today, roughly 2 times their original investment - a 16.33% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 91.10, which is 92.8% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 43.42, which is 8.1% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 58.71.